IS THIS THE BEST BIOTECH GROWTH STOCK?



I've held Editas Medicine as one of my top holdings for a couple of years now, this π—£π—”π—§π—œπ—˜π—‘π—–π—˜ seems to be paying off with the stock rising 200% this month!


I have been expecting this surge for a long time and I think this could just be the start! 𝗦𝗒 what is causing this rise 𝗔𝗑𝗗 how high can Editas go!


WHAT THE HELL IS EDITAS MEDICINE?


Editas is a biotech company that specialises in genome editing.


OKAY... WHAT IS GENOME EDITING?


Genome editing is a method that lets scientists change the DNA of plants, animals and humans. Although plants, animals… and humans have been selectively bred for decades, scientists have advanced this process by learning how to genetically modify the 𝗗𝗑𝗔 of plants to produce foods with less fats, gluten and greater resistance to bacteria!


Now we know that manipulating the DNA of plants doesn’t result in flesh eating zombie pineapples, scientists are beginning to explore the use of genome editing in humans! Early-stage trials are underway to see how effective gene-editing and more specifically 𝗖π—₯π—œπ—¦π—£π—₯ (a new gene editing tool) is at treating numerous diseases from cancer to blindness!


The global genome editing market is expected to triple in size over the next 5 years. However these estimates should be considered conservative given how the current pandemic has highlighted our need to better understand immunology and gene-editing is at the π—–π—¨π—§π—§π—œπ—‘π—š π—˜π——π—šπ—˜ of this industry!


WHY IS EDITAS MEDICINE STOCK RISING?


Editas is not the only gene-editing company doing extremely well this year! The entire sector is getting a 𝗕𝗒𝗒𝗦𝗧 for a number of reasons including:


⚑ This year scientists used gene-editing technology to create successful cancer fighting cells for the first time.


⚑ Vertex Pharmaceuticals provided very positive data on their CRISPR based therapy to treat beta thalassemia


⚑ CRISPR is now being commonly used to engineer mice and accelerate vaccine development


⚑ Breakthroughs have been made using CRISPR to improve the cultivation of rice to tackle world hunger


⚑ Last week, the CEO of Ark Invest - Cathie Wood said that she expects the biggest upside surprises are going to come from the genomic space


𝗧𝗛𝗔𝗧 π—¦π—”π—œπ——, Editas Medicine has delivered some exciting news of it’s own…


⚑ The company submitted a request with FDA to begin a phase 1/2 study of EDIT-301 in treating sickle cell disease


⚑ Editas is evaluating the use of another pipeline candidate (Edit-101) to treat a leading cause of blindness


⚑ The company not only holds the most patents in the gene-editing industry but they recently extended their partnerships with MIT & Harvard which will give Editas exclusive rights to Crispr technologies developed by these 2 prestigious schools until 2024.


⚑ Oh and revenue grew over 400% this year!


All of the above is great news for Editas medicine! However, more importantly the progression of CRISPR & gene-editing could be huge for humanity! If data from upcoming clinical studies is as positive as the findings from 𝗣π—₯π—˜-clinical studies – CRISPR has the potential to help millions of people through agricultural advancements and the treatment of disease.


Therefore, the total 𝗔𝗗𝗗π—₯π—˜π—¦π—¦π—”π—•π—Ÿπ—˜ 𝗠𝗔π—₯π—žπ—˜π—§ π—¦π—œπ—­π—˜ for gene-editing companies is beginning to look enormous. Successful companies in this sector will see huge share price appreciation and Editas is more likely than any to succeed thanks to their early mover advantage, patents and exclusive partnerships with some of the world’s greatest universities!


HOW HIGH CAN EDITAS GO?


I posted this comment 7 months ago:


β€œπΌ'π‘š π‘Žπ‘π‘œπ‘’π‘‘ π‘‘π‘œ π‘‘π‘œ π‘Žπ‘› 𝐴𝑅𝐾 π‘–π‘›π‘£π‘’π‘ π‘‘π‘šπ‘’π‘›π‘‘ 𝑠𝑑𝑦𝑙𝑒 $𝑇𝑆𝐿𝐴 π‘π‘Ÿπ‘–π‘π‘’ π‘‘π‘Žπ‘Ÿπ‘”π‘’π‘‘ β„Žπ‘’π‘Ÿπ‘’ π‘Žπ‘›π‘‘ π‘π‘Ÿπ‘’π‘‘π‘–π‘π‘‘ π‘‘β„Žπ‘Žπ‘‘ πΈπ‘‘π‘–π‘‘π‘Žπ‘  𝑀𝑒𝑑𝑖𝑐𝑖𝑛𝑒 𝑀𝑖𝑙𝑙 π‘Ÿπ‘’π‘Žπ‘β„Ž $75 π‘π‘’π‘Ÿ π‘ β„Žπ‘Žπ‘Ÿπ‘’ (+300%) 𝑖𝑛 2021!”


I am still yet to trim my position in the stock despite Editas currently trading above $80. I believe it will be a volatile ride, however I would not be surprised if Editas Medicine one day commanded a market cap of 𝟰𝟬-πŸ΄πŸ¬π—―π—»β€¦ Up alongside the likes of Illumina.


The stock is flying and therefore could be due a pullback, long term though Editas Medicine is a π—›π—¨π—šπ—˜ 𝗕𝗨𝗬!




Make sure to check out these popular blog posts!



WILL BITCOIN REACH $1,000,000


SHOULD YOU BUY AURORA CANNABIS


2 REASONS TO BUY ALIBABA




#tradeinplaces #trading #trade #learntotrade #learntoinvest #etoro #finance #financialfreedom #investing #travelblog #travelling #stocks #stockmarket #stockstowatch #investor #investment #howtoinvest #howtotrade #marketcap #ipo #movingaverage #correction #volume #pricetarget #beta #dividend #leverage #spread #stocksplit #blockchain #cryptocurrency #alibaba #jd.com #ecommerce #bilibili #pinduoduo #bitcoin #ethereum #eth #2020 #2021

BLOG POSTS

POPULAR POSTS

INSTAGRAM

 

Disclaimer: All trading involves risk. Only invest money that you can afford to lose and remember that past performance doesn’t necessarily guarantee future results. Everything posted by me is for educational purposes only. I am not a financial advisor and no information on this website or any accounts linked with myself should be considered as financial advice. Remember, all trades are at your own risk. 

Β© 2020 TradeinPlaces
  • YouTube
  • Instagram Social Icon
  • etoro
  • Email